Ahsan Alam, MDCM, M.Sc.
Chronic kidney disease
acute kidney injury
autosomal dominant polycystic kidney disease
kidney transplantation
clinical epidemiology
MeDiC | Metabolic Disorders and Complications Program
Our Researchers
The Metabolic Disorders and Complications Program (MeDiC) brings together a team of outstanding research scientists who share the goal of developing new diagnostic tools, treatments and health policies for obesity, diabetes and osteoporosis, along with their complications, including kidney failure, heart disease, fatty liver/cirrhosis, dementia and stroke.
More than one in three Canadians are affected by common and chronic metabolic disorders. The MeDiC Program unites multidisciplinary researchers to study these problems in both adults and children. Each member of the MeDiC program is also affiliated with at least one of the research centres at the Research Institute of the McGill University Health Centre: the Centre for Translational Biology, the Centre for Innovative Medicine and the Centre for Outcomes Research and Evaluation.
To learn more about the MeDiC program, visit our Events, News and Contact Us pages.
Filters
Displaying 53 result(s).
|
|
|
Sero Andonian, MDEndourology kidney stone disease radiation safety medical education minimally invasive surgery |
|
|
Alexis Baass, MD, M.Sc.Lipidology cardiovascular risk metabolism clinical biochemistry cardiovascular prevention |
|
|
Paul Barré, MD, FRCPC, CSPQchronic kidney disease hemodialysis metabolic bone disease polycystic kidney disease anemia |
|
Andrew Bateman, PhDProgranulin neuroprotection tissue repair growth factors cell communication CTB |
|
Barry Bedell, MD, PhDImaging MRI PET image processing neuropathology CTB |
|
John Bergeron, D. Phil.quantitative proteomics subcellular Fractionation electron microscopy systems biology protein secretion and endocytosis CTB |
|
|
David Buckeridge, MD, PhDbiosurveillance public health medical informatics CORE |
|
Sergio Burgos, PhDnutrition metabolism insulin resistance skeletal muscle CTB |
|
Stéphanie Chevalier, RD, PhDnutrition metabolism sarcopenia aging lung cancer CTB |
|
Tyler Churchward-Venne, PhDSkeletal muscle resistance and endurance exercise protein and amino acid metabolism stable isotope tracers nutrition and muscle health |
|
|
Andrey Cybulsky, MDcell injury glomerulonephritis phospholipases protein kinases stress proteins CTB |
|
Deborah Da Costa, PhDMental health behavioural medicine e-health pregnancy/postpartum chronic illnesses CORE |
|
Kaberi Dasgupta, MD, M.Sc.diabetes prevention diabetes reversal diabetes management physical activity eating behaviours CORE |
|
Gustavo Duque, MD, PhD, FRACP, FGSAosteoporosis sarcopenia osteosarcopenia aging geriatrics |
|
George Fantus, MD, FRCPCInsulin resistance tyrosine kinase and phosphatase glucose metabolism diabetes complications oxidative stress CTB |
|
David Goltzman, MDcalcium and mineral metabolism hormonal regulation bone metabolism osteoporosis parathyroid disorders CTB |
|
Steven Grover, MDclinical epidemiology clinical guidelines computer modelling cost effectiveness health promotion CORE |
|
Ahmad Haidar, PhDType 1 diabetes • clinical research • artificial pancreas systems • automated insulin delivery system • randomized controlled trials CTB |
|
|
Bertrand Jean-Claude, M.Sc., PhDKinase inhibitors anti-cancer drugs pharmacokinetics molecular modeling CTB |
|
Maia Kokoeva, PhDObesity diabetes hypothalamus leptin receptor leptin sensing CTB |
|
Richard Kremer, MD, PhDvitamin D parathyroid hormone related peptide (PTHrP) breast cancer skeletal metastasis circulating tumour cells CTB |
|
|
Stéphane Laporte, PhDG protein-coupled receptor molecular pharmacology cell imaging cardiovascular diseases pre-term birth. CTB |
|
Louise Larose, PhDintracellular signaling adaptor proteins unfolded protein response insulin resistance obesity and diabetes CTB |
|
|
Serge Lemay, MDtyrosine kinase adaptor proteins acute kidney injury cell signaling CTB |
|
Jun-Li Liu, PhDCCN5/WISP2 pancreatic islets growth and development transgenic mice knockout mice CTB |
|
|
Errol Marliss, MD, FRCPCNutrition metabolism diabetes obesity insulin resistance CTB |
|
|
José Morais, MDprotein requirements with aging muscle protein regulation insulin resistance sarcopenia frailty CTB |
|
Suzanne Morin, MD, M.Sc., FRCP, FACPOsteoporosis • fractures • bone mineral density • administrative healthcare databases • atypical femur fractures • rehabilitation • clinical practice guidelines CORE |
|
|
Romina Pace, MD, M.Sc.Indigenous health diabetes cardiovascular risk factors health services research database analysis CORE |
|
Vassilios Papadopoulos, PhDsteroids neurosteroids pharmacology drug discovery endocrinology CTB |
|
Steven Paraskevas, MD, PhDislets of Langerhans type 1 diabetes cell death inflammation ischemia-reperfusion injury CTB |
|
Shafaat Rabbani, MDBreast and prostate cancer DNA methylation proteases and growth factors bone metastasis cancer progression CTB |
|
Elham Rahme, PhDpharmacoepidemiology drug utilisation drug adverse events tumour necrosis factor inhibitors anticoagulants CORE |
|
|
Juan-Andres Rivera, MDendocrine cancer neuroendocrine tumors acromegaly multidisciplinary teams |
|
Christian Rocheleau, PhDepidermal growth factor receptor (EGFR) Ras protein Caenorhabditis elegans Rab proteins vesicular trafficking CTB |
|
|
Paul Sabatini, PhDcentral nervous system feeding behaviour energy expenditure obesity brainstem hypothalamus CTB |
|
|
Shaifali Sandal, MD, FRCPCKidney transplantation • living donor • nephrology • clinical research CIM |
|
|
Ruth Sapir-Pichhadze, B.Med.Sc., MD, M.Sc., PhD, FRCPCkidney transplantation nephrology clinical epidemiology clinical research histocompatibility CORE |
|
Hiroaki Sato, MD, PhDcatabolic response to surgery clinical outcomes cardiac anesthesia |
|
|
Thomas Schricker, MD, PhDcatabolic response to surgery clinical outcomes perioperative nutrition |
|
Mark Sherman, MDHyperlipidemia diabetes dyslipidemia |
|
Robert Sladek, MDgenetics type 2 diabetes obesity |
|
Rita Suri, MD, M.Sc.dialysis • frequent dialysis • randomized trials • quality of life • blood pressure • COVID-19 CORE |
|
Tomoko Takano, MD, PhDnephrotic syndrome proteinuria podocytes Rho-GTPases cytoskeleton CTB |
|
Elena Torban, PhDkidney development planar cell polarity cilia formation and ciliophaties glomerular disease mouse models of human kidney diseases CTB |
|
Emilie Trinh, MD, M.Sc.Nephrology peritoneal dialysis home hemodialysis intensive hemodialysis |
|
|
George Tsoukas, MDEndocrinology GLP-1 diabetes cardiology endocrinology |
|
Jeremy Van Raamsdonk, PhD, M.Scaging biological resilience neurodegeneration Parkinson's disease Huntington's disease CTB |
|
Simon Wing, MDubiquitin muscle wasting spermatogenesis cachexia diabetes CTB |
|
|
Jean-François Yale, MD, FRCPCclinical trials in diabetes hypoglycemia intensive management of diabetes adherence |